Ireland· IE-PA-PA0711/317/001
Solifenacin succinate/Tamsulosin hydrochloride Rowex 6 mg/0.4 mg modified-release tablets
A tamsulosin und solifenacin product containing solifenacin succinate + tamsulosin hydrochloride, registered in Ireland by Rowex Limited,. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tamsulosin und solifenacin is registered in 9 of 19 countries.
Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Tamsulosin und solifenacin · ATC G04CA53
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Solifenacin succinate + Tamsulosin hydrochloride
- Manufacturer
- Rowex Limited,
- Country
- Ireland (IE)
- ATC code
- G04CA53
- ATC class
- Tamsulosin und Solifenacin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0711/317/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tamsulosin und solifenacin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- NetherlandsJomil 6 mg/0,4 mg, tabletten met gereguleerde afgifteHeaton k.s.
- SpainBITAMSOL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGLaboratorios Q Pharma S.L.
- United KingdomSolifenacin 6mg / Tamsulosin 400microgram modified-release tabletsTorrent Pharma (UK) Ltd
- PolandBeplasot+pharma arzneimittel GmbH
- GermanySolifenacin/Tamsulosin HeumannHeumann Pharma Gmbh & Co. Generica Kg
- NorwaySolifenacin/Tamsulosin NewburyNewbury Pharmaceuticals AB
- FinlandSolifenacin/Tamsulosin STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Solicomp, Solifenacin/Tamsulosin Stada
- Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
- Bulgaria · Везира, Везомни
- Cyprus · Nefilin
- Czechia · Beplasot, Jomil
- Germany · Solifenacin/Tamsulosin Heumann, Solifenacin/Tamsulosin Ratiopharm
- Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
- Estonia · Solitombo
- Spain · Blobax, Daital
- Finland · Solifenacin/Tamsulosin Stada, Urizia
- France · Vecalmys
- United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
- Greece · Desoltam, Nefilin
- Croatia · Beplasot, Semquest
- Hungary · Mingerlan, Örgunderin
- Iceland · Soltamcin
- Italy · Luracin, Solifenacina E Tamsulosin Mylan
- Lithuania · Solitombo
- Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
- Malta · Jomil
- Netherlands · Jomil, Mingerlan
- Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
- Poland · Beplasot, Mingerlan
- Portugal · Blatan, Solifenacina + Tansulosina Generis
- Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
- Sweden · Urizia
- Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
- Slovakia · Jomil, Solifenacín/Tamsulozín Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc69c536-4455-4fb6-92c2-eb4355cfee4b GET /v1/drugs/cc69c536-4455-4fb6-92c2-eb4355cfee4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"G04CA53"
],
"strength": null,
"pa_number": "PA0711/317/001",
"substances": [
"Solifenacin succinate",
"Tamsulosin hydrochloride"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "26/05/2023",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0101-154-021"
}See everything about tamsulosin und solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.